company background image
4116

BenQ Medical Technology TPEX:4116 Stock Report

Last Price

NT$72.10

Market Cap

NT$3.2b

7D

-8.2%

1Y

139.1%

Updated

08 Aug, 2022

Data

Company Financials
4116 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends0/6

4116 Stock Overview

BenQ Medical Technology Corporation engages in the manufacture, assembly, maintenance, repair, wholesale, retail, leasing, and sale of medical equipment and consumables in Taiwan, Mainland China, India, and internationally.

BenQ Medical Technology Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BenQ Medical Technology
Historical stock prices
Current Share PriceNT$72.10
52 Week HighNT$92.50
52 Week LowNT$25.80
Beta0.53
1 Month Change12.13%
3 Month Change38.12%
1 Year Change139.14%
3 Year Change88.99%
5 Year Change100.28%
Change since IPO89.12%

Recent News & Updates

Shareholder Returns

4116TW Medical EquipmentTW Market
7D-8.2%-3.4%0.1%
1Y139.1%-8.2%-14.4%

Return vs Industry: 4116 exceeded the TW Medical Equipment industry which returned -8.2% over the past year.

Return vs Market: 4116 exceeded the TW Market which returned -14.4% over the past year.

Price Volatility

Is 4116's price volatile compared to industry and market?
4116 volatility
4116 Average Weekly Movement12.6%
Medical Equipment Industry Average Movement5.2%
Market Average Movement5.1%
10% most volatile stocks in TW Market8.4%
10% least volatile stocks in TW Market2.5%

Stable Share Price: 4116 is more volatile than 90% of TW stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: 4116's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
1989405Michael Guanhttps://www.benqmedicaltech.com

BenQ Medical Technology Corporation engages in the manufacture, assembly, maintenance, repair, wholesale, retail, leasing, and sale of medical equipment and consumables in Taiwan, Mainland China, India, and internationally. The company offers operating tables, surgical lights, ultrasound systems, medical and protective masks, medical display monitors, and IQOR integrated systems. It is also involved in the wholesaling and retailing of information software; sale of medical drugs; management consultation services; and trading business.

BenQ Medical Technology Fundamentals Summary

How do BenQ Medical Technology's earnings and revenue compare to its market cap?
4116 fundamental statistics
Market CapNT$3.21b
Earnings (TTM)NT$143.16m
Revenue (TTM)NT$2.21b

22.4x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4116 income statement (TTM)
RevenueNT$2.21b
Cost of RevenueNT$1.53b
Gross ProfitNT$685.65m
Other ExpensesNT$542.49m
EarningsNT$143.16m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)3.21
Gross Margin30.99%
Net Profit Margin6.47%
Debt/Equity Ratio35.3%

How did 4116 perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

15%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is 4116 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4116?

Other financial metrics that can be useful for relative valuation.

4116 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.8x
Enterprise Value/EBITDA18x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 4116's PE Ratio compare to its peers?

4116 PE Ratio vs Peers
The above table shows the PE ratio for 4116 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average24.1x
6797 Taiwan Advanced Nanotech
4.1xn/aNT$2.8b
4106 Apex Medical
23.8xn/aNT$2.5b
1733 Apex Biotechnology
12.4xn/aNT$2.7b
6796 Medimaging Integrated Solution
50.4xn/aNT$3.6b
4116 BenQ Medical Technology
22.7xn/aNT$3.2b

Price-To-Earnings vs Peers: 4116 is good value based on its Price-To-Earnings Ratio (22.7x) compared to the peer average (22.7x).


Price to Earnings Ratio vs Industry

How does 4116's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

Price-To-Earnings vs Industry: 4116 is expensive based on its Price-To-Earnings Ratio (22.7x) compared to the TW Medical Equipment industry average (19.6x)


Price to Earnings Ratio vs Fair Ratio

What is 4116's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4116 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.4x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4116's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 4116 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4116 (NT$72.9) is trading below our estimate of fair value (NT$76.52)

Significantly Below Fair Value: 4116 is trading below fair value, but not by a significant amount.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is BenQ Medical Technology forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


16.4%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as BenQ Medical Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

Past Performance

How has BenQ Medical Technology performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


11.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 4116 has high quality earnings.

Growing Profit Margin: 4116's current net profit margins (6.5%) are higher than last year (3.7%).


Past Earnings Growth Analysis

Earnings Trend: 4116's earnings have grown by 11.2% per year over the past 5 years.

Accelerating Growth: 4116's earnings growth over the past year (164.9%) exceeds its 5-year average (11.2% per year).

Earnings vs Industry: 4116 earnings growth over the past year (164.9%) exceeded the Medical Equipment industry 19%.


Return on Equity

High ROE: 4116's Return on Equity (11.3%) is considered low.


Discover strong past performing companies

Financial Health

How is BenQ Medical Technology's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 4116's short term assets (NT$1.6B) exceed its short term liabilities (NT$932.2M).

Long Term Liabilities: 4116's short term assets (NT$1.6B) exceed its long term liabilities (NT$661.6M).


Debt to Equity History and Analysis

Debt Level: 4116 has more cash than its total debt.

Reducing Debt: 4116's debt to equity ratio has increased from 11.6% to 35.3% over the past 5 years.

Debt Coverage: 4116's debt is well covered by operating cash flow (36.8%).

Interest Coverage: 4116's interest payments on its debt are well covered by EBIT (16.6x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is BenQ Medical Technology current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


0.69%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 4116's dividend (0.69%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (2.55%).

High Dividend: 4116's dividend (0.69%) is low compared to the top 25% of dividend payers in the TW market (6.64%).


Stability and Growth of Payments

Stable Dividend: 4116 is not paying a notable dividend for the TW market, therefore no need to check if payments are stable.

Growing Dividend: 4116 is not paying a notable dividend for the TW market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: 4116 is not paying a notable dividend for the TW market.


Cash Payout to Shareholders

Cash Flow Coverage: 4116 is not paying a notable dividend for the TW market.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Michael Guan

4.92yrs

Tenure

Mr. Michael Guan serves as President since September 2017 and Acts Spokesman at BenQ Medical Technology Corporation. He had served as general manager of BenQ Medical Technology Corp. Since September 2017....


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

BenQ Medical Technology Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: BenQ Medical Technology Corporation
  • Ticker: 4116
  • Exchange: TPEX
  • Founded: 1989
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: NT$3.213b
  • Shares outstanding: 44.57m
  • Website: https://www.benqmedicaltech.com

Number of Employees


Location

  • BenQ Medical Technology Corporation
  • No. 46, Zhouzi Street
  • 7th Floor
  • Taipei
  • 114
  • Taiwan

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/08 00:00
End of Day Share Price2022/08/05 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.